VEXAS syndrome

New guidelines and consensus this year

1. American College of Rheumatology Guidance Statement for Diagnosis and Management of VEXAS Developed by the International VEXAS Working Group Expert Panel
   Arthritis Rheumatol2026 Mar

1. Hypomethylating Therapy in VEXAS Syndrome: Disease Modification Beyond Bridging to Transplant
   Am J Hematol2026 NovPMID 42618968
2. Orf-Like Ulcerated Digital Nodule as a Cutaneous Manifestation of VEXAS Syndrome
   Int J Dermatol2026 NovPMID 42557836
3. Cutaneous manifestations of VEXAS syndrome in a tertiary centre cohort
   J Eur Acad Dermatol Venereol2026 Oct 17PMID 42888904
4. Schnitzler syndrome vs VEXAS syndrome: Differential diagnosis and response to IL-1 inhibitors in three cases
   Actas Dermosifiliogr2026 Oct 16PMID 42887861
5. [Recommendations of the Groupe Francophone des Myélodysplasies (GFM) - Diagnostic approach and management of myelodysplastic syndromes, chronic myelomonocytic leukemias, and VEXAS syndrome]
   Bull Cancer2026 Oct 15PMID 42881104Review
6. Early-onset VEXAS syndrome mimicking orbital cellulitis and successfully treated with allogeneic hematopoietic stem cell transplantation
   J Hematop2026 Oct 6PMID 42836952
7. Oscillation and Lung Expansion Therapy as Rescue Airway Clearance in Critically Ill Adults: A Case Series
   Pulm Ther2026 Oct 5PMID 42834317
8. Evaluating the Efficacy of Cytokine-Directed Therapies in the Management of VEXAS Syndrome
   ACR Open Rheumatol2026 OctPMID 42782167
9. Unique Aspects of Allogeneic Hematopoietic Stem Cell Transplantation in VEXAS Syndrome: One Size Does Not Fit All
   Am J Hematol2026 OctPMID 42560116
10. Assessing the Frequency of VEXAS-Related Canonical UBA1 Mutations in Myelodysplastic Syndrome Patients
    Eur J Haematol2026 OctPMID 42107927